Serological profiling of the human virome and ALS risk in a military population
军人人群中人类病毒组和 ALS 风险的血清学分析
基本信息
- 批准号:10117845
- 负责人:
- 金额:$ 50万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2023-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A potential role of viral infections in ALS has long been suspected, but it remains uncertain. Numerous common
viruses are neurotropic and can cause neurological diseases, including encephalitis, meningitis, and acute
flaccid paralysis, but attempts to demonstrate viral infections in individuals with ALS have given inconsistent
results. Recent experimental work has demonstrated that viral infections may disrupt the normal distribution and
metabolism of RNA binding proteins, including TDP43. For example, infection with Coxsackievirus B3 causes
segregation of TDP43 in the cytoplasm and its cleavage into two fragments, one of which tends to aggregate
and has a dominant negative effect on TDP43 function. The formation of cytoplasmic TDP43 inclusions is a
consistent pathological feature in sporadic ALS, as well as in many cases of frontotemporal dementia. It has
therefore been hypothesized that viral infections can trigger a process of disruption and aggregation of TDP43,
which could then propagate from cell to cell, even in the absence of the virus. Numerous other effects of viral
infection on neuronal and glial cells could also contribute to ALS pathology. We propose therefore to conduct an
exploratory study of the entire human virome (> 400 species and strains) in repeated blood samples collected
years before the onset of the first symptoms of ALS. We will use a recently developed phage display library
expressing 481,966 overlapping peptides derived from all vertebrate and arboviruses (VirScan). By exploring
the virome of healthy young adults who years later developed ALS, we can identify viral infections that are
associated with an increased risk. Further, we will measure serum concentrations of neurofilament light chain
(NfL), a sensitive marker of neurodegeneration to investigate the relation between viral infections and NfL
elevations. Such a unique study is made possible by the databases maintained by the Armed Forces Health
Surveillance Branch and the over 60 million serum samples archived in the Department of Defense Serum
Repository. These samples have been collected from over 11 million young men and women who served in the
US Army, Navy, Marines, and Air Force for screening for HIV infection. Each individual has contributed on
average with a sample every two years starting at the time of entry into active duty. By profiling the virome in
repeated samples, it is possible to identify past and new infections in individuals who developed ALS and
compare this pattern with that of controls matched by age, sex, and ethnicity who remained healthy. Based on
our preliminary work, we expect to be able to identify over 150 incident ALS cases with available serum samples
for the proposed investigation. Our team has been conducting research based on the Department of Defense
Serum Repository for over 15 years and has thus a long history of collaboration with military institutions for this
purpose. This study will be conducted in collaboration with investigators at the Uniformed Services University for
the Health Sciences and with a physician specialized in ALS diagnosis and care at the Massachusetts General
Hospital.
长期以来,人们一直怀疑病毒感染在ALS中的潜在作用,但仍不确定。许多常见
病毒是嗜神经性的,可引起神经系统疾病,包括脑炎、脑膜炎和急性
弛缓性麻痹,但试图证明ALS患者的病毒感染,
结果最近的实验工作表明,病毒感染可能会破坏正态分布,
RNA结合蛋白的代谢,包括TDP43。例如,感染柯萨奇B3病毒会导致
TDP43在细胞质中分离并裂解成两个片段,其中一个倾向于聚集
并且对TDP43功能具有显性负效应。细胞质TDP43包涵体的形成是一个重要的因素。
在散发性ALS中以及在许多额颞叶痴呆病例中具有一致的病理特征。它有
因此假设病毒感染可以触发TDP43的破坏和聚集过程,
即使在没有病毒的情况下,它也可以在细胞间传播。病毒的许多其他影响
神经元和神经胶质细胞的感染也可能有助于ALS病理学。因此,我们建议进行一项
在重复采集的血液样本中对整个人类病毒组(> 400种和菌株)进行探索性研究
在ALS的第一个症状出现前几年。我们将使用最近开发的噬菌体展示库
表达481,966个源自所有脊椎动物和虫媒病毒的重叠肽(VirScan)。通过探索
健康年轻人的病毒组在多年后发展为ALS,我们可以识别出
与风险增加有关。此外,我们将测量神经丝轻链的血清浓度,
(NfL),神经退行性变的敏感标志物,以研究病毒感染与NfL之间的关系
海拔这样一个独特的研究是可能的数据库维护的武装部队卫生
监控分支和超过6000万份血清样本存档在国防部血清
仓库。这些样本是从1100多万在美国服役的年轻男女中收集的。
美国陆军、海军、海军陆战队和空军用于筛查HIV感染。每个人都对
从开始服役时起每两年进行一次抽样调查。通过分析病毒组,
重复的样本,有可能确定过去和新的感染的个人谁发展ALS和
将这一模式与年龄、性别和种族相匹配的健康对照组进行比较。基于
我们的初步工作,我们预计能够确定超过150事件ALS病例与可用的血清样本
进行拟议中的调查我们的团队一直在进行研究,
血清储存库超过15年,因此与军事机构合作的历史很长。
目的.这项研究将与美国陆军大学的研究人员合作进行,
在马萨诸塞州总医院,
医院
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALBERTO ASCHERIO其他文献
ALBERTO ASCHERIO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALBERTO ASCHERIO', 18)}}的其他基金
Biomarkers and risk factors for prodromal Parkinson's disease and its progression
帕金森病前驱期及其进展的生物标志物和危险因素
- 批准号:
10594036 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Biomarkers and risk factors for prodromal Parkinson's disease and its progression
帕金森病前驱期及其进展的生物标志物和危险因素
- 批准号:
10417436 - 财政年份:2022
- 资助金额:
$ 50万 - 项目类别:
Serological profiling of the human virome and ALS risk in a military population
军人人群中人类病毒组和 ALS 风险的血清学分析
- 批准号:
10252746 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Serological profiling of the human virome and ALS risk in a military population
军人人群中人类病毒组和 ALS 风险的血清学分析
- 批准号:
10438144 - 财政年份:2020
- 资助金额:
$ 50万 - 项目类别:
Prospective Study of Vitamin D and MS Risk in African Americans
非裔美国人维生素 D 和多发性硬化症风险的前瞻性研究
- 批准号:
10242084 - 财政年份:2018
- 资助金额:
$ 50万 - 项目类别:
Prospective study of vitamin D and MS risk in African Americans
非裔美国人维生素 D 和多发性硬化症风险的前瞻性研究
- 批准号:
10018657 - 财政年份:2018
- 资助金额:
$ 50万 - 项目类别:
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
维生素 D、EB 病毒感染、吸烟和多发性肺疾病的风险
- 批准号:
8228025 - 财政年份:2011
- 资助金额:
$ 50万 - 项目类别:
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
维生素 D、EB 病毒感染、吸烟和多发性肺疾病的风险
- 批准号:
8449146 - 财政年份:2011
- 资助金额:
$ 50万 - 项目类别:
Vitamin D, Epstein-Barr virus infection, and cigarette smoking and risk of multip
维生素 D、EB 病毒感染、吸烟和多发性肺疾病的风险
- 批准号:
8084442 - 财政年份:2011
- 资助金额:
$ 50万 - 项目类别:
相似国自然基金
柴胡类生药鉴定与质量评价的二元条形码系统的研究
- 批准号:30873387
- 批准年份:2008
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Target identification with systematic CRISPR-based chemical-genetic profiling in human HAP1 cells
在人类 HAP1 细胞中使用基于 CRISPR 的系统化化学基因分析进行靶点识别
- 批准号:
23K23491 - 财政年份:2024
- 资助金额:
$ 50万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Engineering T cells to overcome inhibitory receptor signals that limit the efficacy of adoptive cell therapy against ovarian cancer
改造 T 细胞以克服抑制性受体信号,这些信号限制了过继性细胞疗法对卵巢癌的疗效
- 批准号:
10526155 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别:
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
- 批准号:
10404412 - 财政年份:2023
- 资助金额:
$ 50万 - 项目类别: